Discordant fetal phenotype of hypophosphatasia in two siblings.
Satoru IkenoueKei MiyakoshiTomohiro IshiiYu SatoToshimitsu OtaniYohei AkibaYoshifumi KasugaDaigo OchiaiTadashi MatsumotoYosuke IchihashiYohei MatsuzakiKanako TachikawaToshimi MichigamiGen NishimuraKazushige IkedaTomonobu HasegawaMamoru TanakaPublished in: American journal of medical genetics. Part A (2017)
Hypophosphatasia (HPP) is an autosomal recessive metabolic disorder with impaired bone mineralization due to mutations in the ALPL gene. The genotype-phenotype correlation of this disorder has been widely described. Here, we present two affected siblings, whose fetal phenotypes were discordant. A 31-year-old Japanese woman, G0P0, was referred to our institution because of fetal micromelia. After obstetric counseling, the pregnancy was terminated at 21 weeks' gestation. Post-mortem radiographs demonstrated severely defective mineralization of the skeleton. The calvarial, spinal, and tubular bones were mostly missing. Only the occipital bones, mandible, clavicles, ribs, one thoracic vertebra, ilia, and tibia were relatively well ossified. The radiological findings suggested lethal HPP. Genetic testing for genomic DNA extracted from the umbilical cord identified compound heterozygous mutations in the ALPL gene (c.532T>C, p.Y178H; c.1559delT, p.Leu520Argfs*86). c.532T>C was a novel variant showing no residual activity of the protein by the functional analysis. The parents were heterozygous carriers. In the next pregnancy, biometric values on fetal ultrasonography at 20 and 26 weeks' gestation were normal. At 34 weeks, however, a small chest and shortening of distal long bones came to attention. The neonate delivered at 41 weeks showed serum ALP of <5U/L. Radiological examination showed only mild thoracic hypoplasia and metaphyseal mineralization defects of the long bones. ALP replacement therapy was introduced shortly after birth, and the neonate was discharged at day 22 without respiratory distress. Awareness of discordant fetal phenotypes in siblings with HPP precludes a diagnostic error, and enables early medical intervention to mildly affected neonates.
Keyphrases
- gestational age
- replacement therapy
- preterm birth
- intellectual disability
- spinal cord
- umbilical cord
- smoking cessation
- copy number
- mesenchymal stem cells
- preterm infants
- randomized controlled trial
- healthcare
- genome wide
- early onset
- magnetic resonance imaging
- pregnant women
- low birth weight
- minimally invasive
- cell free
- binding protein
- contrast enhanced
- circulating tumor
- single molecule
- hepatitis c virus
- transcription factor
- magnetic resonance
- bone marrow
- body composition